Companies: 10,795·Total market cap: $144.5T
NextCure, Inc.

NextCure, Inc.

NXTCNASDAQHealthcare● Active
$2.78
$-0.01(-0.36%)
Market Cap$7449672
P/E Ratio—
52W High$15.74
52W Low$2.65
SEC Filings

NextCure, Inc. (NXTC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001661059 · NXTC · NASDAQ · as of Jun 9, 2026

Filing snapshot

362
Total Filings
8-K
Latest Form
2026-06-01
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001661059 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-05
Fiscal Year End
Mar 5, 2026
Accession No.
0001104659-26-024137
Primary Document
nxtc-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001661059 · Accession 0001104659-26-024137

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-01Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-01
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-06
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-24
View
DEF 14AProxy Statement
FORM DEF 14A
2026-04-24
View
10-KAnnual Report
10-K
2026-03-05
View
8-KCurrent Report
8-K
2026-03-05
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-03-05
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-12
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-29
View
Showing 1–15 of 244 filingsForm 4 / 144 hidden· 362 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001661059  |  Exchange: NASDAQ · Healthcare

NextCure, Inc. (NASDAQ: NXTC) has submitted 362 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001661059, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is NextCure, Inc.'s most comprehensive regulatory disclosure. The most recent NextCure, Inc. 10-K was filed on 2026-03-05 for fiscal year ending 2026. Historical NXTC 10-K annual reports are available from 2016 through 2026.

Investors researching NextCure, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
QTTB SEC Filings →ANTX SEC Filings →VRCA SEC Filings →BOLD SEC Filings →PLUR SEC Filings →PSTV SEC Filings →TAOX SEC Filings →JSPR SEC Filings →
→ NXTC Financials→ NXTC Earnings→ NXTC Insider Trades

Frequently Asked Questions

NXTC SEC Filings · 8 questions

NextCure, Inc. (NXTC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 362 filings and access original documents at no cost. NextCure, Inc.'s CIK is 0001661059.

NXTC SEC filingsNextCure, Inc. SEC documentsfind NXTC 10-K